Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer

Summary

This is a monocentric prospective non randomized phase 0 clinical trial targeting patients with colon cancer for whom an upfront surgery has been advised by the pluridisciplinary team.

Timeline

Start

2016-05

Primary completion

2017-11

Completion

2017-11

Outcome

Outcome not reported

Stopped (Enrollment): “none participant has been enrolled and recruited during the first year after competent autority autorisation.”

Drugs

Indications